Studies Addressing Rare Neurodegenerative Diseases including ALS
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This Food and Drug Administration opportunity funds studies addressing rare neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), supporting research that advances understandin…
- Deadline
- Not specified
- Posted
- Aug 14, 2024
- Award amount
- Amount not specified
In plain English
This Food and Drug Administration opportunity funds studies addressing rare neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), supporting research that advances understanding and treatment. It targets research institutions, academic medical centers, and similar organizations with relevant scientific capacity rather than individuals or small organizations. Detailed eligibility, award amounts, and deadlines are not published here because the opportunity is forecasted; confirm requirements in the official notice before applying.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from Food and Drug Administration — soonest deadline first.
Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
Food and Drug Administration · Amount varies · No deadline listed
Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
Food and Drug Administration · Amount varies · No deadline listed
Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Also listed under Food and Drug Administration.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.